PART I . Overview Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases. At Day One, we aim to identify and develop breakthrough medicines with the goal of improving the outcomes and life trajectories of patients of any age facing serious diseases starting from Day One. Our search & development strategy enables us to find, acquire, and develop...
Q2 FY2026 — expected 2026-08-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001193125-26-066956 | EDGAR | 120K words |
| 2025-02-25 | 2024-12-31 | 0000950170-25-026654 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0000950170-24-020212 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0000950170-23-006269 | EDGAR | — |
| 2022-03-07 | 2021-12-31 | 0000950170-22-002959 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001193125-25-264649 | EDGAR | 82K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103012 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064436 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0000950170-24-118958 | EDGAR | — |
| 2024-08-02 | 2024-06-30 | 0000950170-24-089945 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053612 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059485 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039118 | EDGAR | — |
| 2023-05-01 | 2023-03-31 | 0000950170-23-016046 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022667 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014859 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009734 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-06 | 0001193125-26-095174 | EDGAR | 53K words |
| 2026-03-02 | 0001193125-26-084267 | EDGAR | — |
| 2026-02-24 | 0001193125-26-066926 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009834 | EDGAR | — |
| 2026-01-06 | 0001104659-26-001127 | EDGAR | — |
| 2025-11-24 | 0001193125-25-292096 | EDGAR | — |
| 2025-11-13 | 0001104659-25-110812 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264608 | EDGAR | — |
| 2025-10-10 | 0001193125-25-237072 | EDGAR | — |
| 2025-08-05 | 0000950170-25-102969 | EDGAR | — |
95 total filings indexed. 68 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001845337 |
| Ticker | DAWN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report